We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+6.07%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$4.05B
AUM Growth
+$503M
Cap. Flow
+$454M
Cap. Flow %
11.2%
Top 10 Hldgs %
55.84%
Holding
654
New
120
Increased
131
Reduced
191
Closed
155

Top Buys

Rank Stock Value
1
K
Kellanova
K
+$269M
2
SRCL
Stericycle Inc
SRCL
+$141M
3
MRO
Marathon Oil Corporation
MRO
+$108M
4
CHX
ChampionX
CHX
+$103M
5
SPR
Spirit AeroSystems
SPR
+$95.3M

Top Sells

Rank Stock Value
1
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
+$149M
2
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
+$81.8M
3
SWN
Southwestern Energy Company
SWN
+$56.7M
4
UNP icon
Union Pacific
UNP
+$24.2M
5
X
US Steel
X
+$20.2M

Sector Composition

Rank Sector Weight
1 Energy 20.91%
2 Technology 19.62%
3 Healthcare 14.36%
4 Industrials 11.13%
5 Consumer Staples 9.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PTCT icon
251
PTC Therapeutics
PTCT
$5.91B
$1.17M 0.03%
31,435
-1,565
-5% -$52.4K
ADI icon
252
Analog Devices
ADI
$184B
$1.15M 0.03%
5,000
-2,500
-33% -$563K
SNOW icon
253
Snowflake
SNOW
$110B
$1.15M 0.03%
+10,000
New +$1.23M
ESTA icon
254
Establishment Labs
ESTA
$2.33B
$1.14M 0.03%
26,358
-2,087
-7% -$90.7K
AVB icon
255
AvalonBay Communities
AVB
$26.6B
$1.14M 0.03%
5,049
+1,449
+40% +$313K
IQV icon
256
IQVIA
IQV
$38.3B
$1.13M 0.03%
4,763
-1,553
-25% -$367K
IMCR icon
257
Immunocore
IMCR
$1.75B
$1.09M 0.03%
35,112
-4,902
-12% -$178K
ALCY
258
DELISTED
Alchemy Investments Acquisition Corp 1
ALCY
$1.09M 0.03%
100,248
-3,238
-3% -$35K
APLE icon
259
Apple Hospitality REIT
APLE
$3.77B
$1.09M 0.03%
73,404
-56,573
-44% -$819K
ARGX icon
260
argenx
ARGX
$54.8B
$1.08M 0.03%
+2,000
New +$1.01M
MRSN
261
DELISTED
Mersana Therapeutics
MRSN
$1.08M 0.03%
22,801
+1,029
+5% +$45.4K
HYAC
262
DELISTED
Haymaker Acquisition Corp 4
HYAC
$1.07M 0.03%
100,248
-3,238
-3% -$34.3K
IOVA icon
263
Iovance Biotherapeutics
IOVA
$2.77B
$1.07M 0.03%
+113,777
New +$1.08M
AFYA icon
264
Afya
AFYA
$1.27B
$1.04M 0.03%
+60,897
New +$1.06M
XFOR icon
265
X4 Pharmaceuticals
XFOR
$393M
$1.04M 0.03%
51,645
+12,961
+34% +$270K
FNA
266
DELISTED
Paragon 28, Inc.
FNA
$1.01M 0.02%
150,818
-15,925
-10% -$121K
NVNO
267
enVVeno Medical
NVNO
$6.78M
$995K 0.02%
8,458
+1,864
+28% +$342K
KPTI icon
268
Karyopharm Therapeutics
KPTI
$44.2M
$993K 0.02%
79,745
+6,252
+9% +$77.7K
COLD icon
269
Americold
COLD
$4.11B
$990K 0.02%
+35,017
New +$1M
QURE icon
270
uniQure
QURE
$3.15B
$977K 0.02%
198,223
+17,284
+10% +$113K
PECO icon
271
Phillips Edison & Co
PECO
$5.24B
$977K 0.02%
+25,909
New +$924K
MNDY icon
272
monday.com
MNDY
$3.7B
$972K 0.02%
+3,500
New +$866K
AURA icon
273
Aura Biosciences
AURA
$799M
$952K 0.02%
106,898
+16,279
+18% +$140K
PLRX icon
274
Pliant Therapeutics
PLRX
$65M
$952K 0.02%
84,885
+7,885
+10% +$98.7K
PKST
275
DELISTED
Peakstone Realty Trust
PKST
$948K 0.02%
+69,531
New +$910K
9 10
11
12 13

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
SAG
SageView Advisory Group Newport Beach, California $2.96B AUM 15.81% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return

UBS O'Connor's Q3 2024 Portfolio in Review

As of Q3 2024, UBS O'Connor held 654 positions worth $4.05B, up 14% from $3.55B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

UBS O'Connor deployed $454M of net new capital in Q3 2024, opening 120 new positions and adding to 131 existing holdings. Its largest new stake was Kellanova: 3,778,689 shares worth $305M.

By sector, the portfolio is most concentrated in Energy at 21% of assets, down from 27% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was US Steel, an estimated $20.2M trimmed.

  • UBS O'Connor's largest Q3 2024 buy was Kellanova: 3,778,689 shares worth $305M.
  • UBS O'Connor added most to Stericycle Inc in Q3 2024, an estimated $141M increase.
  • UBS O'Connor's biggest Q3 2024 reduction was US Steel, cutting an estimated $20.2M.
  • UBS O'Connor fully exited Equitrans Midstream Corporation Common Stock in Q3 2024, selling an estimated $149M.
  • UBS O'Connor's ten largest holdings make up 56% of its $4.05B portfolio in Q3 2024.
  • UBS O'Connor opened 120 new positions and closed 155 in Q3 2024.
  • UBS O'Connor's portfolio value rose 14% quarter-over-quarter to $4.05B.

Based on UBS O'Connor's 13F filing for Q3 2024, filed 14 Nov 2024.